Total-body cutaneous examination, total-body photography, and dermoscopy in the care of a patient with xeroderma pigmentosum and multiple melanomas

Archives of Dermatology

Volumn 145, Issue 8, 2009, Pages 910-915

  Green, W Harris ^a   Wang, Steven Q ^b   Cognetta Jr , Armand B ^c  

^a EAST CAROLINA UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Dermatology Associates of Tallahassee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; ISOTRETINOIN; SUNSCREEN;

ACTINIC KERATOSIS; ADULT; ARTICLE; ATAXIA; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; CEREBELLUM ATROPHY; DYSKERATOSIS; EPILUMINESCENCE MICROSCOPY; EYE PROTECTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOGRAPHY; PHOTOPHOBIA; PHOTOSENSITIVITY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN EXAMINATION; SKIN SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TREATMENT REFUSAL; TUMOR BIOPSY; TUMOR VOLUME; VISUAL IMPAIRMENT; XERODERMA PIGMENTOSUM;

ADULT; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DERMOSCOPY; FEMALE; HUMANS; MELANOMA; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, RADIATION-INDUCED; PHOTOGRAPHY; PHYSICAL EXAMINATION; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM;

EID: 68949086439     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.87     Document Type: Article

References (35)

1. Hebra FK. On Disease of the Skin, Including Exanthemata: Textbook of Dermatology. In: Kaposi M, ed. London, England: New Sydenham Society; 1874.
2. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer: the xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130(8):1018-1021.
3. Moussaid L, Benchikhi H, Boukind EH, et al. Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients [in French]. Ann Dermatol Venereol. 2004;131(1, pt 1):29-33.
4. Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol. 1985;3(1):33-69.
5. Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77. Natl Cancer Inst Monogr. 1981;57:1-1082.
6. Bech-Thomsen N, Wulf HC, Ullman S. Xeroderma pigmentosum lesions related to ultraviolet transmittance by clothes. J Am Acad Dermatol. 1991;24(2, pt 2):365-368.
7. Davis BE, Koh HK, Rohrer TE, Gonzalez E, Cleaver JE. Sunlight avoidance and cancer prevention in xeroderma pigmentosum. Arch Dermatol. 1994;130(6):806-808.
8. Kocabalkan O, Ozgür F, Erk Y, Gürsu KG, Güngen Y. Malignant melanoma in xeroderma pigmentosum patients: report of five cases. Eur J Surg Oncol. 1997;23(1):43-47.
9. Kopf AW, Salopek TG, Slade J, Marghoob AA, Bart RS. Techniques of cutaneous examination for the detection of skin cancer. Cancer. 1995;75(2)(suppl):684-690.
10. Shriner DL, Wagner RF Jr, Glowczwski JR. Photography for the early diagnosis of malignant melanoma in patients with atypical moles. Cutis. 1992;50(5):358-362.
11. Halpern AC. The use of whole body photography in a pigmented lesion clinic. Dermatol Surg. 2000;26(12):1175-1180.
12. Slue W, Kopf AW, Rivers JK. Total-body photographs of dysplastic nevi. Arch Dermatol. 1988;124(8):1239-1243.
13. Nachbar F, Stolz W, Merkle T, et al. The ABCD rule of dermatoscopy: high prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol. 1994;30(4):551-559.
14. Lucas CR, Sanders LL, Murray JC, Myers SA, Hall RP, Grichnik JM. Early melanoma detection: nonuniform dermoscopic features and growth. J Am Acad Dermatol. 2003;48(5):663-671.
15. Carli P, De Giorgi V, Betti R, et al. Relationship between cause of referral and diagnostic outcome in pigmented lesion clinics: a multicentre survey of the Italian Multidisciplinary Group on Melanoma (GIPMe). Melanoma Res. 2003;13(2):207-211.
16. Soyer HP, Argenziano G, Zalaudek I, et al. Three-point checklist of dermoscopy: a new screening method for early detection of melanoma. Dermatology. 2004;208(1):27-31.
17. Wang SQ, Kopf AW, Koenig K, Polsky D, Nudel K, Bart RS. Detection of melanomas in patients followed up with total cutaneous examinations, total cutaneous photography, and dermoscopy. J Am Acad Dermatol. 2004;50(1):15-20.
18. Malvehy J, Puig S, Martí-Laborda RM. Dermoscopy of skin lesions in two patients with xeroderma pigmentosum. Br J Dermatol. 2005;152(2):271-278.
19. Tucker MA, Fraser MC, Goldstein AM, et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer. 2002;94(12):3192-3209.
20. Feit NE, Dusza SW, Marghoob AA. Melanomas detected with the aid of total cutaneous photography. Br J Dermatol. 2004;150(4):706-714.
21. Levy JL, Trelles MA, Levy A, Besson R. Photography in dermatology: comparison between slides and digital imaging. J Cosmet Dermatol. 2003;2(3-4):131-134.
22. Malvehy J, Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol. 2002;20(3):297-304.
23. Kokoska MS, Currens JW, Hollenbeak CS, Thomas JR, Stack BC Jr. Digital vs 35-mm photography: to convert or not to convert? Arch Facial Plast Surg. 1999;1(4):276-281.
24. Provost N, Kopf AW, Rabinovitz HS, et al. Comparison of conventional photographs and telephonically transmitted compressed digitized images of melanomas and dysplastic nevi. Dermatology. 1998;196(3):299-304.
25. Nelson BR, Fader DJ, Gillard M, Baker SR, Johnson TM. The role of dermabrasion and chemical peels in the treatment of patients with xeroderma pigmentosum. J Am Acad Dermatol. 1995;32(4):623-626.
26. Epstein EH Jr, Bwik PG, Cohen IK, Deckers P. Dermatome shaving in the treatment of xeroderma pigmentosum. Arch Dermatol. 1972;105(4):589-590.
27. König A, Friederich HC, Hoffmann R, Happle R. Dermabrasion for the treatment of xeroderma pigmentosum. Arch Dermatol. 1998;134(2):241-242.
28. Cox SE, Roberts LJ, Bergstresser PR. Prevention of skin cancer in xeroderma pigmentosum: the physician as advocate. J Am Acad Dermatol. 1993;29(6):1045-1046.
29. Hamouda B, Jamila Z, Najet R, et al. Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum [letter]. J Am Acad Dermatol. 2001;44(6):1054.
30. Carter VH, Smith KW, Noojin RO. Xeroderma pigmentosum: treatment with topically applied fluorouracil. Arch Dermatol. 1968;98(5):526-527.
31. Boussen H, Zwik J, Mili-Boussen I, et al. Therapeutic results of 5-fluorouracil in multiple and unresectable facial carcinoma secondary to xeroderma pigmentosum [in French]. Therapie. 2001;56(6):751-754.
32. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988;318(25):1633-1637.
33. Moshell AN. Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin. Cutis. 1989;43(5):485-490.
34. Kang S, Barnhill RL, Mihm MC Jr, Fitzpatrick TB, Sober AJ. Melanoma risk in individuals with clinically atypical nevi. Arch Dermatol. 1994;130(8):999-1001.
35. Zalaudek I, Kittler H, Marghoob AA, et al. Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch Dermatol. 2008;144(4):509-513.